MOG and myeloid sarcoma: Recently, antibodies to myelin oligodendrocyte glycoprotein (MOG) were reported in a subset of patients with a NMOSD phenotype seronegative for aquaporin-4 antibodies [124–127] and some patients with MS [128, 129].